SubsidieMeestersConfident®, the digital simulation platform that revolutionizes cardiovascular interventions
Confident is an AI-driven platform that creates 3D virtual models for cardiovascular interventions, enabling personalized treatment planning to improve patient outcomes and reduce surgical risks.
Projectdetails
Introduction
Confident is a disruptive cloud-based platform for digital planning of cardiovascular interventions. Today, many patients do not have access to treatment as their case is considered too high risk for surgery.
Background
Created in 2017, PrediSurge has developed a unique AI-based solution that enables physicians to select the best therapeutic strategy for a specific patient.
Technology Overview
Confident builds 3D virtual models of patients' anatomy and implants with real-life biomechanical behavior. For the first time, physicians can simulate procedures to predict and prevent post-operative complications.
Innovation
Our patented digital twin technology completely redefines the planning potentialities of:
- Endovascular aneurysms repair
- Transcatheter mitral valve repair
Future Goals
With EIC, PrediSurge will accelerate its business development to become a world leader in predictive software solutions for cardiovascular precision medicine. We will digitalize cardiovascular healthcare to change the lives of millions of patients.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 9.085.800 |
Tijdlijn
| Startdatum | 1-11-2022 |
| Einddatum | 31-10-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- PREDISURGEpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Development and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AIImplicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools. | EIC Accelerator | € 2.488.359 | 2025 | Details |
AI-based clinical software for fully automated Cardiac Magnetic Resonance reportingAI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes. | EIC Accelerator | € 1.753.842 | 2022 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Paradigm shift in stroke: accurate diagnosis and evaluation of all treatment options in any hospital, at any timeMethinks aims to transform stroke diagnosis by enabling all hospitals to evaluate treatment options using standard imaging, reducing time-to-treatment and improving patient outcomes globally. | EIC Accelerator | € 2.495.415 | 2023 | Details |
ELEM Virtual Heart Populations for SupercomputersELEMs V.Heart is a supercomputer platform for in-silico clinical trials using digital avatars to evaluate therapy outcomes, enhancing safety, efficacy, and precision medicine while reducing trial risks. | EIC Accelerator | € 2.482.096 | 2023 | Details |
Development and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AI
Implicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools.
AI-based clinical software for fully automated Cardiac Magnetic Resonance reporting
AI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Paradigm shift in stroke: accurate diagnosis and evaluation of all treatment options in any hospital, at any time
Methinks aims to transform stroke diagnosis by enabling all hospitals to evaluate treatment options using standard imaging, reducing time-to-treatment and improving patient outcomes globally.
ELEM Virtual Heart Populations for Supercomputers
ELEMs V.Heart is a supercomputer platform for in-silico clinical trials using digital avatars to evaluate therapy outcomes, enhancing safety, efficacy, and precision medicine while reducing trial risks.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Schaalbare AI voor patiënten met pijn op de borstHet project ontwikkelt een AI-algoritme dat cardiologen ondersteunt bij het aanvragen van CT-scans voor patiënten met pijn op de borst. | 1.1 - Het ve... | € 795.688 | 2024 | Details |
Using CARDIac simulations to run in-silicO clinical TRIALSThis project aims to develop a GPU-accelerated computational platform for simulating cardiac pathologies and device responses, integrating uncertainty quantification to enhance in-silico clinical trials. | ERC Starting... | € 1.499.423 | 2022 | Details |
Med.aiHet Med.ai project ontwikkelt een slimme hoofdcamera voor de medische sector om de kwaliteit en toegankelijkheid van chirurgische zorg te verbeteren met AI-technologie. | Mkb-innovati... | € 200.000 | 2021 | Details |
Data4NeuroData4Neuro ontwikkelt een datagedreven platform voor de neurosurgische industrie om realtime feedback van clinici te verzamelen en inzichten te bieden. | Mkb-innovati... | € 20.000 | 2021 | Details |
Hart in ZichtHet project ontwikkelt een AI-gestuurde applicatie die smartphone- en wearable-technologie combineert voor vroegtijdige risicobeoordeling van hart- en vaatziekten, met als doel ziekenhuisopnames te verminderen. | Mkb-innovati... | € 198.310 | 2022 | Details |
Schaalbare AI voor patiënten met pijn op de borst
Het project ontwikkelt een AI-algoritme dat cardiologen ondersteunt bij het aanvragen van CT-scans voor patiënten met pijn op de borst.
Using CARDIac simulations to run in-silicO clinical TRIALS
This project aims to develop a GPU-accelerated computational platform for simulating cardiac pathologies and device responses, integrating uncertainty quantification to enhance in-silico clinical trials.
Med.ai
Het Med.ai project ontwikkelt een slimme hoofdcamera voor de medische sector om de kwaliteit en toegankelijkheid van chirurgische zorg te verbeteren met AI-technologie.
Data4Neuro
Data4Neuro ontwikkelt een datagedreven platform voor de neurosurgische industrie om realtime feedback van clinici te verzamelen en inzichten te bieden.
Hart in Zicht
Het project ontwikkelt een AI-gestuurde applicatie die smartphone- en wearable-technologie combineert voor vroegtijdige risicobeoordeling van hart- en vaatziekten, met als doel ziekenhuisopnames te verminderen.